Infants with unexplained apneic episodes (Near-Miss for Sudden Infant Death Syndrome (SIDS)), are presumably at increased risk of subsequently dying of SIDS. It has been proposed that these infants exhibit prolonged sleep apnea which contributes to the mechanism leading to death. The objective of this study was to document the incidence of apnea during sleep recordings in 16 Near-Miss infants and compare the findings with those obtained from age and sex matched controls.
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Polygraphic records of 4 sleep and 3 cardiopulmonary variables were obtained during a 12 hour overnight recording. Successive minutes were classified as quiet sleep, active sleep, waking or indeterminate states by trained observers using standard scorin criteria. Respiratory rate and variability were calculated by computer for each minute across the night and related to sleep state. Pauses in breathing 3 3 seconds were identified in both groups. There was a tendency for Near-Miss infants to breathe faster with fewer apnea than controls, but this finding was not statistically significant. A1 though one half of the Near-Miss infants had recurrent prolonged apneic spells, all survived and were normal at 2 years. The proposed relationship between SIDS and apnea is not confined by this study. significantly worse at peak TG levels but then progressively improved to baseline level or better despite only partial TG recovery. Although the immediate changes suggest that IL should not be administered to patients with lung disease, the subsequent TG-unrelated recovery indicates that chronic IL administration does not impair gas exchange. In fact, by an entirely different and as vet unexvlained mechanism. pulmonary gas exsigniflcakly more cerebellar and intraventricular hemorrhage in eonates dying after ventilation via a face mask compared with those ventilated via an endotracheal tube (ETT)l. The intracranial hemorrhage (ICH) has been attributed to severe occipital ompression and head molding from the velcro band attachment for the mask. The 99 survivors (birthweight 51500g) who were ventit ated during the same time period have been followed prospective y for two years to determine the incidence of central nervous vstem seauelae.
EXPERTMENTAL EFFECTS OF INTUALIPID
C Immature Lung Syndrome is seen in premature infants <I500 gm without clinical RDS but with initial chest x-rays suggesting mild RDS (fine, faint granularity without air bronchograms or underexpansion of lung fields, Clin. Res. 24:174A, 1976 ). Seven infants with ILS (birth wt. 996t174gm) h z tracheal aspirate phospholipid determinations on the first day of life comapred with those from a group of premature infants <I500 gm with RDS (birth wt. 1121+145 om) , -.
. . . Twenty-one neonates of drug-dependent mothers were studied prospectively. Of 19 mthers on methadone (MI, 13 were plydrug abusers (PD); 2 mothers were heroin-dependent. Mean birth weigh was 2675 grams f 580 (SD); mean gestational age was 38.0 weeks 2.7 (SD). Eighteen of 21 had birth weights appropriate for dates; 3 were small for dates. All lengths were between 10th an, 90th percentile. Eighteen of 21 head circumferences were betwee the 10th and 90th percentile; 3 fell below the 10th percentile.
Mean maximal weight loss in the first postnatal week was 7.25% of body weight f 3.67% (SD). From 7 to 30 days of age, 16 infants gained weight normally, 3 subnormally and 2 excessively Weight gain corrected for caloric intake was inversely related to severity of withdrawal on day 14 (p<.05), but not on days 7 or 21.
Drug withdrawal was assessed twice daily by standardized score. Mean time of symptom onset was 13.5 hours f 0.7 (SD). No difference in withdrawal severity was seen between the M and PD groups. No correlation was found between withdrawal severity an maternal M dosage late in pregnancy or at delivery. Term infant showed more severe withdrawal than preterm infants. Infants ran domly treated for moderate to severe symptoms with paregoric or phenobarbital showed no difference in modification of withdrawal severity or treatment time required.
